Here’s what you should know:
1. Apollo will discontinue the intragastric balloon, in favor of its own Orbera balloon device.
2. ReShape paid $10 million to close the transactions Dec. 17. ReShape is expected to make future payments on Dec. 17, 2019 and Dec. 17, 2020.
3. ReShape will manufacture the Lap-Band device for up to two years.
4. ReShape Chairman and CEO Dan Gladney said, “The acquisition of the Lap-Band product line adds a clinically proven, FDA-approved, minimally invasive technology with broad insurance coverage and meaningful established revenue and margins to ReShape Lifesciences.”
More articles on gastroenterology:
LPC West acquires California medical office building — 3 insights
HSTpathways partners with California’s 6th largest outpatient surgery provider
Envision, UnitedHealthcare agree to extend payer contract & more — 7 ASC company key notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.